Patents by Inventor Max Grosse

Max Grosse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250054042
    Abstract: Systems, methods, and computer-readable storage media for predicting user interest, and more specifically to defining user interest based on user expressions of intent. The system can receive a list of items, where each item in the list of items has a similar purpose and can be substituted with other items in the list of items, and item content elements associated with items in the list. The system can then identify websites with content that is relevant to the item content elements associated with the list based on relevancy, and identify at least one user that accessed one of the websites, resulting in at least one interested user. The system can then generate, for each user in the set of at least one interested users, a user intent and modify a previously planned interaction with the each user based on the user intent score.
    Type: Application
    Filed: August 8, 2024
    Publication date: February 13, 2025
    Inventors: Brendan Brady, Jun Hong Choi, Manoj Kumar Goyal, Max Gross, Kumaran Ramanathan, Jason Ryan Tenenbown
  • Publication number: 20240150005
    Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.
    Type: Application
    Filed: January 9, 2024
    Publication date: May 9, 2024
    Inventors: Max Gross, Joseph Bruno
  • Patent number: 11866148
    Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: January 9, 2024
    Assignee: SCIMAX TECHNOLOGIES, LLC
    Inventors: Max Gross, Joseph Bruno
  • Patent number: 11716376
    Abstract: A system for managing non-linear transmedia content data is provided. Memory stores a plurality of transmedia content data items and associated linking data which define time-ordered content links between the plurality of transmedia content data items. The plurality of transmedia content data items are arranged into linked transmedia content subsets comprising different groups of the transmedia content data items and different content links therebetween. A control engine receives one or more instructions to create a new time-ordered content link between at least two of the plurality of transmedia content data items. The control engine modifies the linking data stored in the memory to include the new time-ordered content link.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: August 1, 2023
    Assignees: DISNEY ENTERPRISES, INC., ETH ZÜRICH (EIDGENÖSSISCHE TECHNISCHE HOCHSCHULE ZÜRICH)
    Inventors: Max Grosse, Barbara Solenthaler, Peter Kaufmann, Markus Gross, Sasha Schriber
  • Patent number: 11297396
    Abstract: The invention relates to systems and methods for manipulating non-linearly connected transmedia content, in particular for creating, processing and/or managing non-linearly connected transmedia content and for tracking content creation and attributing transmedia content to one or more creators. Specifically, the invention involves creating a transmedia content data item by a first user and storing the transmedia content data item in a data store, along with a record indicating an association between the first user and the transmedia content data item; creating an ordered group of transmedia content data items by a second user, the ordered group comprising a pointer to the transmedia content data item of the first user; and storing the ordered group and a record associating both the first user and the second user with the ordered group in the data store.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: April 5, 2022
    Assignee: Disney Enterprises, Inc.
    Inventors: Rebekkah Laeuchli, Sasha Schriber, Stephan Veen, Markus Gross, Isabel Simo, Max Grosse
  • Patent number: 11269941
    Abstract: Systems and methods are provided for a workflow framework that scriptwriters can utilize when developing scripts. A script can be parsed to identify one or more elements in a script, and various visual representations of the one or more elements and/or a scene characterized in the script can be automatically generated. A user may develop or edit the script which can be presented in a visual and temporal manner. Information parsed from the script can be stored in basic information elements, and used to create a knowledge bases.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: March 8, 2022
    Assignee: Disney Enterprises, Inc.
    Inventors: Sasha Anna Schriber, Rushit Sanghrajka, Wojciech Witon, Isabel Simo, Mubbasir Kapadia, Markus Gross, Daniel Inversini, Max Grosse, Eleftheria Tsipidi
  • Patent number: 11236084
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: February 1, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: George Hynd, Calum Macleod, Samuel Edward Mann, Janusz Jozef Kulagowski, Ian Stansfield, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel
  • Patent number: 11186589
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: November 30, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
  • Patent number: 11180487
    Abstract: The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: November 23, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Simon Richard Green, George Hynd
  • Patent number: 11136311
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: October 5, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
  • Publication number: 20210188840
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoinmmune disorders.
    Type: Application
    Filed: July 4, 2018
    Publication date: June 24, 2021
    Inventors: George HYND, Calum MACLEOD, Samuel Edward MANN, Janusz Jozef KULAGOWSKI, Ian STANSFIELD, Olivier Alexis Georges QUEROLLE, Virginie Sophie PONCELET, Gerhard Max GROSS, Edgar JACOBY, Lieven MEERPOEL
  • Patent number: 11001569
    Abstract: The present invention relates to pharmaceutical agents of formula (I), useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as a cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: May 11, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Simon Richard Green, George Hynd
  • Patent number: 10977287
    Abstract: Systems and methods are provided for a workflow framework that scriptwriters can utilize when developing scripts. A script can be parsed to identify one or more elements in a script, and various visual representations of the one or more elements and/or a scene characterized in the script can be automatically generated. A user may develop or edit the script which can be presented in a visual and temporal manner. Information parsed from the script can be stored in basic information elements, and used to create a knowledge bases.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: April 13, 2021
    Assignee: Disney Enterprises, Inc.
    Inventors: Sasha Anna Schriber, Isabel Simo, Justine Fung, Daniel Inversini, Carolina Ferrari, Max Grosse, Markus Gross
  • Publication number: 20210087182
    Abstract: The present invention relates to pharmaceutical agents of formula (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-KB-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Application
    Filed: January 20, 2017
    Publication date: March 25, 2021
    Inventors: Ian STANSFIELD, Olivier Alexis Georges QUEROLLE, Virginie Sophie PONCELET, Gerhard Max GROSS, Edgar JACOBY, Lieven MEERPOEL, Janusz Jozef KULAGOWSKI, Calum MACLEOD, Samuel Edward MANN, Simon Richard GREEN, George HYND
  • Publication number: 20210060125
    Abstract: The present description relates to methods of treatment and pharmaceutical compositions comprising a Nitric Oxide Synthase-inducer peptide, PnPP-19. Although usable for other purposes, the composition comprising PnPP-19 is useful for treating and/or preventing eye diseases related to intraocular hypertension and/or optic nerve degeneration, such as glaucoma.
    Type: Application
    Filed: September 1, 2020
    Publication date: March 4, 2021
    Inventors: Armando da Silva Cunha Junior, Maria Elena de Lima Perez Garcia, Carolina Nunes da Silva, Lays Fernanda Nunes Dourado, Perla Villani Borges da Silva, Paulo Gustavo Sampaio Lacativa, Gerhard Max Gross, Iron Francisco de Paula Junior
  • Publication number: 20210032267
    Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.
    Type: Application
    Filed: February 6, 2020
    Publication date: February 4, 2021
    Inventors: Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel, Simon Richard Green, George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann
  • Patent number: 10905738
    Abstract: Synthetic peptides that are modulators of smooth muscle tone and compositions thereof, including pharmaceutical compositions containing a peptide, make it possible to treat indications in those in need of modulation of the smooth muscle tone, including, for example, benign prostate hyperplasia (BPH), Raynaud's syndrome, Pulmonary Arterial hypertension (PAH), systemic arterial hypertension (SAH) and hyper-reactivity of airways associated with asthma, COPD, pulmonary fibrosis, silicosis, allergic bronchopulmonary aspergillosis, hereditary angioedema, and neonatal hypoxemic respiratory failure. Although makeable in other ways, the synthetic peptides are makeable by recombinant methods or synthetic pathways.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: February 2, 2021
    Assignee: Biozeus Desenvolvimento De Produtos Biofarmacêuticos
    Inventors: Caio Victor Machado França do Nascimento, Diego Allonso Rodrigues dos Santos da Silva, Perla Villani Borges da Silva, Maria Elena De Lima Perez Garcia, Carolina Nunes da Silva, Adriano Monteiro de Castro Pimenta, Marcella Nunes de Melo Braga, Paulo Gustavo Sampaio Lacativa, Iron Francisco de Paula Junior, Gerhard Max Gross
  • Publication number: 20210016899
    Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.
    Type: Application
    Filed: August 31, 2020
    Publication date: January 21, 2021
    Inventors: Max Gross, Joseph Bruno
  • Patent number: 10759513
    Abstract: A floor panel for installation in an aircraft includes a plurality of thermoplastic C-shaped stringers, a consolidated thermoplastic deltoid filler, a thermoplastic upper facing sheet, and a thermoplastic lower facing sheet. The stringers are disposed in a parallel arrangement with one another. The deltoid filler is disposed within a longitudinally-extending notch defined by a pair of adjacent stringers. The upper facing sheet covers an upper surface of the stringers and the deltoid filler. The lower facing sheet covers a lower surface of the stringers and the deltoid filler. The stringers, the deltoid filler, and the upper and lower facing sheets are integrally consolidated forming a unitary construction.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: September 1, 2020
    Assignee: SCIMAX TECHNOLOGIES, LLC
    Inventors: Max Gross, Joseph Bruno
  • Patent number: 10706097
    Abstract: The invention relates to systems and methods for navigating, outputting and displaying non-linearly connected groups of transmedia content. Specifically, the invention involves retrieving, from a database, an ordered group of transmedia content data objects comprising a plurality of transmedia content data objects and linking data, whereby each element of the linking data defines a directional link from one of the transmedia content data objects to another of the transmedia content data objects; generating a two-dimensional graph structure representing the ordered group of transmedia content data objects whereby each graph node corresponds to a transmedia content data object and each graph edge corresponds to an element of the linking data; and outputting the graph structure on a display screen.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: July 7, 2020
    Assignee: Disney Enterprises, Inc.
    Inventors: Rebekkah Laeuchli, Isabel Simo, Max Grosse, Markus Gross, Sasha Schriber, Maria Cabral, Merada Richter